What to do about AI in Health
Create Date:
27 Feb 2024
Last updated:
27 Feb 2024
Report
Other
Third Sector
A blog by MIT that details the issues between drug creation within AI models and regulations in the US. This highlights the problems that AI are currently in drug regulations – especially concerning creating new drugs so rapidly that it might have a negative impact on reducing harmful side effects.
Link: What to do about AI in health?
Why is this important?
It highlights areas of regulation and policy that AI are affecting.
Source Credibility: MIT is a university with leading research in the area of AI
Subject:
AI
AI » Regulation